Financial Summary for the Fiscal Year Ended August 2026 (Japanese GAAP) (Consolidated)

Overview of Results

For the fiscal year ended August 2026, the Company achieved increased revenue of 34,324 million yen (YoY 105.1%). Operating income was 2,455 million yen and ordinary income was 2,390 million yen. Net income amounted to 1,198 million yen due to recording a goodwill impairment loss of 435 million yen as an extraordinary loss. By segment, Healthcare and Pharmaceuticals were the main drivers: Healthcare recorded revenue of 20,034 million yen and Pharmaceuticals 2,569 million yen, with Department Stores, Foodservice, Real Estate & Construction, and Others showing their respective trends. Total assets were 49,046 million yen and net assets were 16,435 million yen.

Outlook and Capital Allocation

For the fiscal year ending August 2027, full-year forecasts are revenue of 17,610 million yen, operating income of 1,272 million yen, ordinary income of 1,215 million yen, and net income attributable to owners of parent of 815 million yen. The Company expects main businesses to remain steady and plans to continue promoting new businesses such as the integration of Rabbit Express into the group, as well as initiatives in the real estate, construction, and tourism sectors. Financial position remains on a stable footing with net assets of 16,435 million yen and an equity ratio of 33.0%.